Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach

Objective: Large randomized clinical trials have shown the efficacy of aspirin, ACE (angiotensin converting enzyme) inhibitors and statins as secondary prevention measures in patients after an acute coronary syndrome with and without ST elevations. Therefore we aimed to determine the effect of a com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zeymer, Uwe (VerfasserIn) , Jünger, Claus Heinrich (VerfasserIn) , Zahn, Ralf (VerfasserIn) , Bauer, Timm (VerfasserIn) , Bestehorn, Kurt (VerfasserIn) , Senges, Jochen (VerfasserIn) , Gitt, Anselm Kai (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 Jun 2011
In: Current medical research and opinion
Year: 2011, Jahrgang: 27, Heft: 8, Pages: 1563-1570
ISSN:1473-4877
DOI:10.1185/03007995.2011.590969
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1185/03007995.2011.590969
Volltext
Verfasserangaben:Uwe Zeymer, Claus Jünger, Ralf Zahn, Timm Bauer, Kurt Bestehorn, Jochen Senges & Anselm Gitt

MARC

LEADER 00000caa a2200000 c 4500
001 1831116774
003 DE-627
005 20230710095059.0
007 cr uuu---uuuuu
008 230116s2011 xx |||||o 00| ||eng c
024 7 |a 10.1185/03007995.2011.590969  |2 doi 
035 |a (DE-627)1831116774 
035 |a (DE-599)KXP1831116774 
035 |a (OCoLC)1389738251 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Zeymer, Uwe  |e VerfasserIn  |0 (DE-588)1163486884  |0 (DE-627)1027835694  |0 (DE-576)508027608  |4 aut 
245 1 0 |a Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach  |c Uwe Zeymer, Claus Jünger, Ralf Zahn, Timm Bauer, Kurt Bestehorn, Jochen Senges & Anselm Gitt 
264 1 |c 17 Jun 2011 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.01.2023 
520 |a Objective: Large randomized clinical trials have shown the efficacy of aspirin, ACE (angiotensin converting enzyme) inhibitors and statins as secondary prevention measures in patients after an acute coronary syndrome with and without ST elevations. Therefore we aimed to determine the effect of a combination therapy with these three drugs on 1-year mortality after acute myocardial infarction (AMI). Methods: We prospectively followed 9998 survivors of acute myocardial infarction treated with a beta-blocker for 1 year. Patients were divided into three groups according to their therapy with aspirin, ACE inhibitors and statins: 3 drugs, 2 drugs or 0-1 drug. Results: The majority of patients (n = 6260, 62.6%) were treated with 3 drugs, 2986 (29.9%) with 2 drugs and 752 (7.5%) with 0-1 drug. In the univariate analysis 1-year mortality was 4.9%, 9.7% and 13.6%, respectively. After adjusting for confounding factors in the propensity score analysis the odds ratios for 1-year mortality were significantly increased with 0-1 drug (odds ratio 1.67, 95% CI 1.24-2.27) and with 2 drugs (odds ratio 1.54, 95% CI 1.26-1.87) in comparison with the group treated with all 3 drugs. However, in the ACOS registry the treatment was left to the discretion of the physician. This could lead to a selection bias, which cannot be fully eliminated by using multiple regression analysis. Conclusions: A combination therapy with aspirin, an ACE inhibitor and a statin reduces 1-year mortality in patients after AMI. Therefore a polypill approach with these three agents should be considered to increase drug compliance and reduce mortality after acute myocardial infarction. 
650 4 |a Myocardial infarction 
650 4 |a Polypill 
650 4 |a Prognosis 
650 4 |a Secondary prevention 
700 1 |a Jünger, Claus Heinrich  |d 1964-  |e VerfasserIn  |0 (DE-588)131623346  |0 (DE-627)511708262  |0 (DE-576)298632381  |4 aut 
700 1 |a Zahn, Ralf  |e VerfasserIn  |0 (DE-588)1161883231  |0 (DE-627)1025402537  |0 (DE-576)507007905  |4 aut 
700 1 |a Bauer, Timm  |d 1974-  |e VerfasserIn  |0 (DE-588)1171012454  |0 (DE-627)1040366414  |0 (DE-576)513065717  |4 aut 
700 1 |a Bestehorn, Kurt  |d 1950-  |e VerfasserIn  |0 (DE-588)14083902X  |0 (DE-627)703805029  |0 (DE-576)319121976  |4 aut 
700 1 |a Senges, Jochen  |d 1942-  |e VerfasserIn  |0 (DE-588)1027133479  |0 (DE-627)728326620  |0 (DE-576)372508685  |4 aut 
700 1 |a Gitt, Anselm Kai  |d 1964-  |e VerfasserIn  |0 (DE-588)124753132  |0 (DE-627)365720836  |0 (DE-576)294482792  |4 aut 
773 0 8 |i Enthalten in  |t Current medical research and opinion  |d Abingdon : Taylor & Francis Group, 1972  |g 27(2011), 8, Seite 1563-1570  |h Online-Ressource  |w (DE-627)325162158  |w (DE-600)2034331-0  |w (DE-576)325002673  |x 1473-4877  |7 nnas  |a Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach 
773 1 8 |g volume:27  |g year:2011  |g number:8  |g pages:1563-1570  |g extent:8  |a Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach 
856 4 0 |u https://doi.org/10.1185/03007995.2011.590969  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230116 
993 |a Article 
994 |a 2011 
998 |g 124753132  |a Gitt, Anselm Kai  |m 124753132:Gitt, Anselm Kai  |d 50000  |e 50000PG124753132  |k 0/50000/  |p 7  |y j 
998 |g 1027133479  |a Senges, Jochen  |m 1027133479:Senges, Jochen  |d 50000  |e 50000PS1027133479  |k 0/50000/  |p 6 
998 |g 1171012454  |a Bauer, Timm  |m 1171012454:Bauer, Timm  |p 4 
998 |g 1161883231  |a Zahn, Ralf  |m 1161883231:Zahn, Ralf  |p 3 
998 |g 131623346  |a Jünger, Claus Heinrich  |m 131623346:Jünger, Claus Heinrich  |p 2 
998 |g 1163486884  |a Zeymer, Uwe  |m 1163486884:Zeymer, Uwe  |p 1  |x j 
999 |a KXP-PPN1831116774  |e 4248313383 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"17 Jun 2011"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"display":"Zeymer, Uwe","given":"Uwe","family":"Zeymer","role":"aut"},{"family":"Jünger","given":"Claus Heinrich","display":"Jünger, Claus Heinrich","role":"aut"},{"role":"aut","display":"Zahn, Ralf","given":"Ralf","family":"Zahn"},{"role":"aut","given":"Timm","family":"Bauer","display":"Bauer, Timm"},{"role":"aut","display":"Bestehorn, Kurt","family":"Bestehorn","given":"Kurt"},{"role":"aut","display":"Senges, Jochen","given":"Jochen","family":"Senges"},{"role":"aut","family":"Gitt","given":"Anselm Kai","display":"Gitt, Anselm Kai"}],"title":[{"title":"Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach","title_sort":"Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach"}],"note":["Gesehen am 16.01.2023"],"name":{"displayForm":["Uwe Zeymer, Claus Jünger, Ralf Zahn, Timm Bauer, Kurt Bestehorn, Jochen Senges & Anselm Gitt"]},"relHost":[{"note":["Gesehen am 03.02.23"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"1972","publisherPlace":"Abingdon ; Reading ; London","dateIssuedDisp":"1972-","publisher":"Taylor & Francis Group ; Librapharm ; Informa Healthcare"}],"title":[{"title_sort":"Current medical research and opinion","title":"Current medical research and opinion"}],"pubHistory":["1.1972/73 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approachCurrent medical research and opinion","part":{"extent":"8","volume":"27","pages":"1563-1570","text":"27(2011), 8, Seite 1563-1570","year":"2011","issue":"8"},"recId":"325162158","id":{"issn":["1473-4877"],"zdb":["2034331-0"],"eki":["325162158"]}}],"recId":"1831116774","id":{"eki":["1831116774"],"doi":["10.1185/03007995.2011.590969"]},"language":["eng"],"physDesc":[{"extent":"8 S."}]} 
SRT |a ZEYMERUWEJEFFECTSOFA1720